Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 5 | 2025 | 345 | 1.660 |
Why?
|
| Erythrocyte Transfusion | 2 | 2025 | 135 | 1.520 |
Why?
|
| Hemolysis | 1 | 2025 | 114 | 0.910 |
Why?
|
| ADAMTS13 Protein | 2 | 2024 | 67 | 0.880 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2024 | 57 | 0.840 |
Why?
|
| Thrombophilia | 1 | 2020 | 42 | 0.670 |
Why?
|
| Cyclin B | 1 | 2019 | 23 | 0.650 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2019 | 21 | 0.650 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 274 | 0.620 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 237 | 0.590 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2017 | 11 | 0.560 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 236 | 0.560 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2022 | 560 | 0.550 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2017 | 58 | 0.540 |
Why?
|
| Ascites | 1 | 2017 | 111 | 0.530 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 625 | 0.490 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 462 | 0.470 |
Why?
|
| Repressor Proteins | 1 | 2019 | 874 | 0.450 |
Why?
|
| ADAM Proteins | 2 | 2024 | 87 | 0.290 |
Why?
|
| Blood Component Removal | 1 | 2025 | 35 | 0.230 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3170 | 0.230 |
Why?
|
| Transfusion Reaction | 1 | 2025 | 39 | 0.230 |
Why?
|
| Microarray Analysis | 1 | 2024 | 239 | 0.210 |
Why?
|
| von Willebrand Factor | 2 | 2019 | 205 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2023 | 385 | 0.200 |
Why?
|
| Anticoagulants | 3 | 2024 | 625 | 0.200 |
Why?
|
| Gene Duplication | 1 | 2024 | 372 | 0.190 |
Why?
|
| Acute Chest Syndrome | 1 | 2021 | 10 | 0.190 |
Why?
|
| Syndrome | 1 | 2025 | 1176 | 0.190 |
Why?
|
| Warfarin | 1 | 2023 | 132 | 0.190 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2021 | 29 | 0.190 |
Why?
|
| Interferon Type I | 1 | 2022 | 115 | 0.180 |
Why?
|
| Exons | 1 | 2024 | 839 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 187 | 0.180 |
Why?
|
| Thrombosis | 2 | 2024 | 547 | 0.170 |
Why?
|
| Humans | 13 | 2025 | 134145 | 0.170 |
Why?
|
| Seizures | 1 | 2025 | 892 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2023 | 519 | 0.160 |
Why?
|
| Casein Kinase I | 1 | 2019 | 12 | 0.160 |
Why?
|
| Platelet Adhesiveness | 1 | 2019 | 41 | 0.150 |
Why?
|
| Nephrectomy | 1 | 2019 | 181 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 161 | 0.150 |
Why?
|
| Male | 7 | 2025 | 66171 | 0.140 |
Why?
|
| Protein Phosphatase 1 | 2 | 2023 | 55 | 0.130 |
Why?
|
| Microbiota | 1 | 2022 | 443 | 0.130 |
Why?
|
| Blood Platelets | 2 | 2009 | 342 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1312 | 0.120 |
Why?
|
| Apoptosis | 1 | 2023 | 1945 | 0.120 |
Why?
|
| Stroke | 2 | 2021 | 1079 | 0.110 |
Why?
|
| Female | 5 | 2024 | 72004 | 0.110 |
Why?
|
| Child | 4 | 2024 | 25911 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1357 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2009 | 180 | 0.100 |
Why?
|
| Mice | 5 | 2023 | 19044 | 0.090 |
Why?
|
| Prognosis | 1 | 2019 | 5084 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2025 | 17565 | 0.080 |
Why?
|
| Thrombin | 1 | 2009 | 63 | 0.080 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2009 | 65 | 0.080 |
Why?
|
| Hemoglobin A | 1 | 2009 | 22 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2024 | 14895 | 0.080 |
Why?
|
| Complement C3 | 1 | 2009 | 54 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2025 | 13098 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2587 | 0.080 |
Why?
|
| Pregnancy | 1 | 2021 | 7600 | 0.070 |
Why?
|
| Young Adult | 2 | 2025 | 9960 | 0.070 |
Why?
|
| Animals | 5 | 2023 | 36520 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2023 | 1713 | 0.070 |
Why?
|
| Adolescent | 2 | 2024 | 20643 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2024 | 108 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2023 | 45 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 214 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2024 | 202 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2025 | 738 | 0.040 |
Why?
|
| Cell Survival | 1 | 2023 | 890 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2022 | 228 | 0.040 |
Why?
|
| Platelet Aggregation | 2 | 2009 | 125 | 0.040 |
Why?
|
| Infant | 2 | 2024 | 13256 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 329 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 260 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 416 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 367 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 986 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 824 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 1386 | 0.030 |
Why?
|
| Hospitalization | 1 | 2024 | 1908 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1436 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2793 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2022 | 4936 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 3867 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8636 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2009 | 14 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 42 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2009 | 21 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 64 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 66 | 0.020 |
Why?
|
| Enzyme Repression | 1 | 2009 | 4 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 11184 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2009 | 8 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 231 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 165 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2009 | 163 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2009 | 63 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 315 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2009 | 93 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 512 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2009 | 539 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 1860 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 31944 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 4012 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4882 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4802 | 0.010 |
Why?
|